Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


New Legislation Addressing the Opioid Crisis


 

As the 110th General Assembly of the Tennessee State Legislature drew to a close at the end of April, new legislation (SB 2257 / HB 1831) was approved to address a significant part of Gov. Bill Haslam's TN Together Plan to combat the opioid crisis in the state.

As passed by the House and Senate, prescribers will now have additional rules regarding checking the state's controlled substance database and new limits on opioid prescriptions for opioid naïve patients and for acute care patients. Although a strong proponent of proper prescribing, the Tennessee Medical Association had previously opposed several points of the plan based on concerns that setting hard limits on dosing sidestepped clinical judgment and didn't allow physicians to write prescriptions they deemed medically appropriate on a case-by-case basis.

Despite that objection, the new law restricts treatment of an opioid naïve patient to no more than a five-day supply of an opioid and no more than a 30-day supply for an acute care patient. Furthermore, the dosage of a prescribed opioid cannot exceed a daily 40-morphine milligram equivalent (40 MME). However, as part of a compromise with TMA, the law does allow that in "exceptional cases" where the prescriber deems an additional supply of the opioid might be warranted and circumstances exist that would make it difficult for the patient to acquire a second prescription, the provider could issue an opioid naïve patient a second prescription simultaneous to the initial prescription. Written documentation of why the second prescription was written must be included in the patient record, and the provider must counsel the patient or patient representative on the circumstances under which the second prescription could be filled (no sooner than five days or later than 10 days from issuance).

Additional rules for prescribing to acute care patients were also codified including the mandate that a provider must personally assess the patient and obtain informed consent before prescribing an opioid, and other "reasonable, appropriate, and available non-opioid treatments for the pain condition" have been tried first or a contraindication or intolerance of those other options have been documented.

There are a number of exceptions to the rules including inpatient treatment, treatment by certified pain management specialists, and treatment of those in hospice care or who are undergoing active or palliative cancer treatment.


TMA Statement

On April 25, Nita W. Shumaker, MD, 2017-18 president of the Tennessee Medical Association issued the following statement on Tennessee's new opioid law:

"It was clear when Governor Haslam announced his TN Together plan in January that lawmakers were going to do something to try to address the state's opioid abuse epidemic. With the passage of SB 2257 / HB 1831, Tennessee now has one of the most comprehensive and restrictive laws of any state.

"The Tennessee Medical Association was actively engaged in the process and appreciates legislators' willingness to consider input from physician stakeholders. From the beginning and during the past several weeks of negotiations, TMA advocated for a mindful, yet practical, approach to initial opioid supply and dosage. Most importantly, we wanted to make sure it did not unreasonably obstruct patients in legitimate pain from getting the care they need.

"The final bill is substantially improved from the initial version. New restrictions on prescribing and dispensing will no doubt achieve the governor's stated goal of reducing overall initial supply. TMA will educate doctors on the new law as part of our ongoing efforts to promote safe and proper prescribing.

"Tennessee's doctors remain concerned, however, about unintended consequences for patients who because of the new law may have more difficulty accessing effective pain management. There are not enough certified pain specialists in Tennessee to care for Tennesseans experiencing legitimate chronic pain. Meanwhile, exploding use of fentanyl, heroin and other illicit drugs are causing more accidental overdose deaths even as opioid prescriptions decline. We still need a multi-faceted and well-funded strategy including treatment and law enforcement to turn back this epidemic."

New Data Shows Decrease in Opioid Prescribing

A new report published by the IQVIA Institute for Human Data Science ("Medicine Use and Spending in the U.S.," April 2018) shows that Tennesseans filled 6,709,154 opioid prescriptions at retail pharmacies in 2017, a nearly 9 percent decrease from the previous year and a 21.3 percent drop from 2013.

Tennessee outperformed most of its contiguous states and is on par with the national average for year-over-year improvements and five-year trends.

The Tennessee Medical Association pointed to the data as validation of the medical community's ongoing efforts to self-regulate prescribing and reduce initial opioid dosage and supply. "This report shows that Tennessee's medical community is driving real change in the initial supply of opioids in our state, despite the fact that clear data to help us identify who is writing excessive amounts for patients is available only to government regulators," said 2017-18 TMA President Nita W. Shumaker, MD. "Physicians, for decades, were told these medications were completely safe and faced potential litigation if we did not treat pain aggressively. As a result, patients developed unrealistic expectations about pain management. Once we recognized the addictive dangers of these medications, we worked hard to change the culture and improve supervision. The report confirms that we are making progress."

National trends show 22.2 percent fewer opioid prescriptions were filled in 2017 than had been filled in 2013, with every state in the nation showing some reduction in the past year. In 2017, a total of 196 million opioid prescriptions were filled in the United States, representing an 8.9 percent decrease from the prior year - the sharpest single-year decrease reported by IQVIA.

Prescription opioid volumes in the U.S. peaked in 2011 at 240 billion milligrams of morphine milligram equivalents and have declined by 29 percent to 171 billion MMEs.

More Money to Fight Opioid Crisis

In April, Senate Health Committee Chairman Lamar Alexander announced Tennessee will receive a nearly $14 million grant from the Department of Health and Human Services in the state's fight against the opioid crisis. The state received nearly $14 million last year, as well - both grants were funded by the 21st Century Cures Act that Alexander authored and President Obama signed into law in 2016.

"The devastation of the opioid crisis has touched nearly every community in our state, and today's announcement - that Tennessee is set to receive another nearly $14 million to fight its ongoing opioid epidemic - will provide a major boost to Tennesseans on the front lines of a battle that is being waged county by county and doctor's office by doctor's office," Alexander said at the April 18 announcement.

WEB:

TN General Assembly, SB 2257 / HB 1831

 
Share:

Related Articles:


Recent Articles

The 2019 Legislative Agenda

A new governor and many new legislators make 2019 a learning year as the state's top healthcare organizations seek to address a number of old issues and tweak some new solutions unveiled last year.

Read More

Updated Cholesterol Guidelines Take a Personalized Approach

The American Heart Association and American College of Cardiology released updated cholesterol clinical guidelines in November 2018, taking a more nuanced approach to care over a patient's lifetime.

Read More

Sharing Data, Saving Lives

In an increasingly connected medical ecosystem where patient safety, health status improvement, and provider reimbursement are impacted at every point along the continuum, the need to efficiently, securely share data appears to have reached a tipping point.

Read More

New Rules in Heart Disease

A number of guideline changes and updates warrant more education around statin use and blood pressure monitoring, but local cardiologists say the higher standards are a game changer.

Read More

Dr. Ashish Shah: A Heart for Transplant Patients

Dr. Ashish Shah is the driving force behind the growth and innovation at one of the nation's busiest heart transplant programs.

Read More

Heart Monitor

Cardiovascular news of note.

Read More

ECMO Program Thriving at TriStar Centennial

A TriStar Centennial, a team approach is key to hospital's successful ECMO program.

Read More

Alexander Looks for Innovation, Asks Council Fellows for Input

Sen. Lamar Alexander asks stakeholders and future leaders to weigh in on ways to improve health outcomes, lower costs.

Read More

CMS Utilizes Dartboard Approach to Modernizing the Medicare Drug Benefit

Controlling pharmaceutical prices remains a hot topic, judging from the 6,415 comments received in response to the CMS proposed rule: "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses."

Read More

A Conversation with LHC Director Molly Vice

Every company should have a succession plan. LHC plays a key role in planning for the next generation of leaders for an entire industry.

Read More

Email Print
 
 

 

 


Tags:
Bill Haslam, Nita Shumaker, Opioid Crisis, Opioid Naïve, Opioid Prescribing, Opioids, Tennessee Medical Association, TMA
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: